Ginkgo Bioworks Forecast, price target & analysts
Ginkgo Bioworks Target price 2024 - Analyst rating & recommendation
Ginkgo Bioworks Classifications & Recommendation:
Ginkgo Bioworks Price Target
| Target Price | $8.20 |
| Price | $6.37 |
| Potential |
28.73%
register free of charge
|
| Number of Estimates | 5 |
|
5 Analysts have issued a price target Ginkgo Bioworks 2025 .
The average Ginkgo Bioworks target price is $8.20.
This is
28.73%
register free of charge
$10.00
56.99%
register free of charge
$6.00
5.81%
register free of charge
|
|
| A rating was issued by 6 analysts: 1 Analysts recommend Ginkgo Bioworks to buy, 1 to hold and 4 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Ginkgo Bioworks stock has an average upside potential 2025 of
28.73%
register free of charge
|
Sales and Margin forecast 2024, 2025 to 2028
| Dec '23 |
2024 Estimates |
|
|---|---|---|
| Revenue Million $ | 251.46 | 219.33 |
| 47.36% | 12.78% | |
| EBITDA Margin | -238.88% | -121.62% |
| 45.67% | 49.09% | |
| Net Margin | -365.85% | -228.78% |
| 2,691.87% | 37.47% |
6 Analysts have issued a sales forecast Ginkgo Bioworks 2024 . The average Ginkgo Bioworks sales estimate is
This results in the following potential growth metrics:
5 Analysts have issued an Ginkgo Bioworks EBITDA forecast 2024. The average Ginkgo Bioworks EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
1 Analyst has issued a net profit forecast Ginkgo Bioworks 2024 . The average Ginkgo Bioworks net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2028
| Dec '23 |
2024 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -18.37 | -10.02 |
| 1,369.60% | 45.45% | |
| P/E | negative | |
| EV/Sales | 0.77 |
1 Analysts have issued a Ginkgo Bioworks forecast for earnings per share. The average Ginkgo Bioworks <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2024, the Ginkgo Bioworks stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Ginkgo Bioworks...
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
